Cargando…

Polycystic Kidney Disease Drug Development: A Conference Report

Autosomal dominant polycystic kidney disease (ADPKD) is part of a spectrum of inherited diseases that also includes autosomal recessive polycystic kidney disease, autosomal dominant polycystic liver disease, and an expanding group of recessively inherited disorders collectively termed hepatorenal fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liebau, Max C., Mekahli, Djalila, Perrone, Ronald, Soyfer, Belle, Fedeles, Sorin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867973/ https://www.ncbi.nlm.nih.gov/pubmed/36698747 http://dx.doi.org/10.1016/j.xkme.2022.100596

Ejemplares similares

Translational research approaches to study pediatric polycystic kidney disease
por: Liebau, Max Christoph, et al.
Publicado: (2021)

Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective
por: De Rechter, Stéphanie, et al.
Publicado: (2018)

Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial
por: Janssens, Peter, et al.
Publicado: (2020)

Gastrostomy Tube Insertion in Pediatric Patients With Autosomal Recessive Polycystic Kidney Disease (ARPKD): Current Practice
por: Burgmaier, Kathrin, et al.
Publicado: (2018)

The wind of change in the management of autosomal dominant polycystic kidney disease in childhood
por: Gimpel, Charlotte, et al.
Publicado: (2021)

Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?
por: De Rechter, Stéphanie, et al.
Publicado: (2017)

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease
por: Mekahli, Djalila, et al.
Publicado: (2023)

Clinicians’ attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease
por: De Rechter, Stéphanie, et al.
Publicado: (2017)

An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
por: Müller, Roman-Ulrich, et al.
Publicado: (2021)

International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
por: Gimpel, Charlotte, et al.
Publicado: (2019)

Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function
por: Janssens, Peter, et al.
Publicado: (2023)

Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up
por: Schellekens, Pieter, et al.
Publicado: (2023)

Early clinical management of autosomal recessive polycystic kidney disease
por: Liebau, Max Christoph
Publicado: (2021)

Clinical Characteristics and Courses of Patients With Autosomal Recessive Polycystic Kidney Disease-Mimicking Phenocopies
por: Halawi, Abdul A., et al.
Publicado: (2023)

Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD)
por: Burgmaier, Kathrin, et al.
Publicado: (2019)

Standardized 4-point scoring scale of [(18)F]-FDG PET/CT imaging helps in the diagnosis of renal and hepatic cyst infections in patients with autosomal dominant polycystic kidney disease: a validation cohort
por: Demuynck, Selina, et al.
Publicado: (2023)

Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment
por: Haumann, Sophie, et al.
Publicado: (2020)

Recent Progress of the ARegPKD Registry Study on Autosomal Recessive Polycystic Kidney Disease
por: Ebner, Kathrin, et al.
Publicado: (2017)

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial
por: Schaefer, Franz, et al.
Publicado: (2019)

Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease
por: Janssens, Peter, et al.
Publicado: (2021)

Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)
por: Burgmaier, Kathrin, et al.
Publicado: (2020)

A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017)

Systematic review on outcomes used in clinical research on autosomal recessive polycystic kidney disease—are patient-centered outcomes our blind spot?
por: Gimpel, Charlotte, et al.
Publicado: (2021)

Shift from severe hypotension to salt-dependent hypertension in a child with autosomal recessive polycystic kidney disease after bilateral nephrectomies: a case report
por: Ruzgiene, Dovile, et al.
Publicado: (2023)

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease
por: Tangri, Navdeep, et al.
Publicado: (2017)

Disrupting polycystin-2 EF hand Ca(2+) affinity does not alter channel function or contribute to polycystic kidney disease
por: Vien, Thuy N., et al.
Publicado: (2020)

In-Hospital Outcomes of Acute Kidney Injury After Pediatric Cardiac Surgery: A Meta-Analysis
por: Van den Eynde, Jef, et al.
Publicado: (2021)

Glomerular Filtration Rate in Former Extreme Low Birth Weight Infants over the Full Pediatric Age Range: A Pooled Analysis
por: Goetschalckx, Elise, et al.
Publicado: (2020)

ADPedKD: A Global Online Platform on the Management of Children With ADPKD
por: De Rechter, Stéphanie, et al.
Publicado: (2019)

Bilateral hand-assisted laparoscopic nephrectomy in adult polycystic kidney disease patients: a UK centre experience
por: Mak DK, C, et al.
Publicado: (2012)

Persistent Markers of Kidney Injury in Children Who Developed Acute Kidney Injury After Pediatric Cardiac Surgery: A Prospective Cohort Study
por: Van den Eynde, Jef, et al.
Publicado: (2022)

Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
por: Bais, Thomas, et al.
Publicado: (2022)

Editorial: Genetic Kidney Diseases of Childhood
por: Schmidts, Miriam, et al.
Publicado: (2018)

Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions
por: Allegaert, Karel, et al.
Publicado: (2020)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Phenotypic Variability in Siblings With Autosomal Recessive Polycystic Kidney Disease
por: Ajiri, Ramona, et al.
Publicado: (2022)

An Emerging Molecular Understanding and Novel Targeted Treatment Approaches in Pediatric Kidney Diseases
por: Liebau, Max Christoph
Publicado: (2014)

Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Nomenclature for kidney function and disease—executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
por: Levey, Andrew S, et al.
Publicado: (2020)

Lkb1 deficiency confers glutamine dependency in polycystic kidney disease
por: Flowers, Ebony M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mo64o075nsd1ded0ojs5vfdbd7